Mylan Laboratories Ltd

Mylan Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mylan Laboratories Ltd

₹ None%
- close price
Company website
About

Mylan Laboratories Limited,incorporated in India, listed on the Bombay Stock Exchange Limited, the company is engaged in the manufacture and trading of Pharmaceuticals

[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE 13.4 %
  • ROE 20.0 %
  • Face Value ₹
Edit ratios

Pros

  • Company has delivered good profit growth of 87.6% CAGR over last 5 years

Cons

  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.1,358 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
1,159 1,652 1,735 2,279 2,778 3,244 4,120 5,617 6,985
1,109 1,471 2,032 1,988 2,739 2,543 3,289 4,589 6,370
Operating Profit 50 181 -297 291 40 701 830 1,028 615
OPM % 4% 11% -17% 13% 1% 22% 20% 18% 9%
250 50 49 58 841 75 19 -10 1,358
Interest 29 75 99 156 126 52 75 77 255
Depreciation 34 54 61 70 82 104 108 128 367
Profit before tax 237 102 -408 122 673 620 666 813 1,352
Tax % 16% 26% 13% 72% 20% 28% 31% 42% 20%
200 76 -461 34 538 447 457 473 1,076
EPS in Rs 4.95 -29.56 1.94 32.16 27.25 28.61 30.04 69.15
Dividend Payout % 9% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 29%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 88%
3 Years: 18%
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 24%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Equity Capital 31 31 31 31 31 31 31 31 37
Reserves 936 1,019 584 622 1,184 1,617 1,830 2,410 4,310
1,234 1,667 1,698 2,025 927 1,075 1,463 2,062 6,629
872 730 682 907 829 1,300 1,691 1,925 3,637
Total Liabilities 3,073 3,446 2,995 3,585 2,972 4,023 5,016 6,429 14,614
1,672 2,005 1,658 1,886 1,251 1,544 1,767 1,979 6,322
CWIP 124 36 122 180 134 87 116 135 1,021
Investments 45 29 30 42 17 17 0 0 154
1,232 1,376 1,185 1,476 1,570 2,374 3,133 4,314 7,116
Total Assets 3,073 3,446 2,995 3,585 2,972 4,023 5,016 6,429 14,614

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
288 8 66 126 336 231 130 358 359
-1,271 -136 -196 -285 -129 -344 -355 -831 -5,796
884 325 -166 162 -254 112 232 501 5,465
Net Cash Flow -98 197 -296 2 -46 -1 8 28 29

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014
Debtor Days 125 74 84 105 74 73 98 87 119
Inventory Days 234 193 230 194 219 262 253 232 256
Days Payable 265 163 148 137 126 126 140 133 148
Cash Conversion Cycle 93 104 165 161 168 209 211 186 226
Working Capital Days 91 79 109 99 128 144 148 155 177
ROCE % 7% -12% 11% 16% 25% 24% 27% 13%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.

Credit ratings